These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 10986054)

  • 41. Distribution of p53 and K-ras mutations in human lung cancer tissues.
    Gao HG; Chen JK; Stewart J; Song B; Rayappa C; Whong WZ; Ong T
    Carcinogenesis; 1997 Mar; 18(3):473-8. PubMed ID: 9067544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
    Murao K; Kubo Y; Ohtani N; Hara E; Arase S
    Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.
    Soria JC; Rodriguez M; Liu DD; Lee JJ; Hong WK; Mao L
    Cancer Res; 2002 Jan; 62(2):351-5. PubMed ID: 11809677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: a prospective study in high-risk patients without invasive cancer.
    Lamy A; Sesboüé R; Bourguignon J; Dautréaux B; Métayer J; Frébourg T; Thiberville L
    Int J Cancer; 2002 Jul; 100(2):189-93. PubMed ID: 12115568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure.
    Scesnaite A; Jarmalaite S; Mutanen P; Anttila S; Nyberg F; Benhamou S; Boffetta P; Husgafvel-Pursiainen K
    Mutagenesis; 2012 Jul; 27(4):423-9. PubMed ID: 22217548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
    Sarkar FH; Li Y; Vallyathan V
    Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
    Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
    Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of K-RAS and P53 mutations in sputum samples.
    Gao W; Keohavong P
    Methods Mol Biol; 2005; 291():217-33. PubMed ID: 15502226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
    Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of K-ras point mutations in sputum from patients with adenocarcinoma of the lung by point-EXACCT.
    Somers VA; Pietersen AM; Theunissen PH; Thunnissen FB
    J Clin Oncol; 1998 Sep; 16(9):3061-8. PubMed ID: 9738576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p14ARF hypermethylation is common but INK4a-ARF locus or p53 mutations are rare in Merkel cell carcinoma.
    Lassacher A; Heitzer E; Kerl H; Wolf P
    J Invest Dermatol; 2008 Jul; 128(7):1788-96. PubMed ID: 18219279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
    Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
    Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer.
    Russo AL; Thiagalingam A; Pan H; Califano J; Cheng KH; Ponte JF; Chinnappan D; Nemani P; Sidransky D; Thiagalingam S
    Clin Cancer Res; 2005 Apr; 11(7):2466-70. PubMed ID: 15814621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of Mutations in K-ras and p53 Genes in Sputum and Plasma Samples.
    Zhang L; Gao W; Keohavong P
    Methods Mol Biol; 2020; 2102():373-394. PubMed ID: 31989568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alterations of the p16(ink4a) gene in resected nonsmall cell lung tumors and exfoliated cells within sputum.
    Chen JT; Chen YC; Wang YC; Tseng RC; Chen CY; Wang YC
    Int J Cancer; 2002 Apr; 98(5):724-31. PubMed ID: 11920642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on clinicopathological features of lung cancer patients with K-ras/p53 gene alterations: comparison between younger and older groups.
    Kashii T; Mizushima Y; Lima CE; Noto H; Sato H; Saito H; Kusajima Y; Kitagawa M; Yamamoto K; Kobayashi M
    Oncology; 1995; 52(3):219-25. PubMed ID: 7715905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of K-ras and p53 mutations by "mutant-enriched" PCR-RFLP.
    Schuermann M
    Methods Mol Med; 2003; 75():325-33. PubMed ID: 12407750
    [No Abstract]   [Full Text] [Related]  

  • 58. Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: correlation with smoking.
    Georgiou E; Valeri R; Tzimagiorgis G; Anzel J; Krikelis D; Tsilikas C; Sarikos G; Destouni C; Dimitriadou A; Kouidou S
    Eur J Cancer Prev; 2007 Oct; 16(5):396-402. PubMed ID: 17923809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.
    Sanchez-Cespedes M; Decker PA; Doffek KM; Esteller M; Westra WH; Alawi EA; Herman JG; Demeure MJ; Sidransky D; Ahrendt SA
    Cancer Res; 2001 Mar; 61(5):2092-6. PubMed ID: 11280771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
    Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.